Envair Electrodyne Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve pursuant to Regulation 29 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Envair Electrodyne Ltd has informed BSE that its Board of Directors will meet on Thursday, 12 February 2026, to consider and approve the un-audited financial results for the quarter ended 31 December 2025 (Q3 FY26). The intimation is filed under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This is a routine compliance filing ahead of the results announcement, with no financial figures or business details disclosed yet.
This is a standard pre-results intimation with no immediate impact on shareholders. Investors should watch for the actual Q3 FY26 results on or after 12 February 2026, which could move the stock depending on the numbers reported.